134 related articles for article (PubMed ID: 33729682)
1. High cost of illness in fibromyalgia patients in Iran, irrespective of disease severity: A prospective cost study.
Gharibpoor F; Nasrollahzadeh E; Ghavidel-Parsa B; Ghaffari ME; Bidari A
Int J Rheum Dis; 2021 May; 24(5):671-680. PubMed ID: 33729682
[TBL] [Abstract][Full Text] [Related]
2. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.
Chandran A; Schaefer C; Ryan K; Baik R; McNett M; Zlateva G
J Manag Care Pharm; 2012; 18(6):415-26. PubMed ID: 22839682
[TBL] [Abstract][Full Text] [Related]
3. Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains.
Perrot S; Schaefer C; Knight T; Hufstader M; Chandran AB; Zlateva G
BMC Musculoskelet Disord; 2012 Feb; 13():22. PubMed ID: 22340435
[TBL] [Abstract][Full Text] [Related]
4. Cost of illness and illness perceptions in patients with fibromyalgia.
Vervoort VM; Vriezekolk JE; Olde Hartman TC; Cats HA; van Helmond T; van der Laan WH; Geenen R; van den Ende CH
Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S74-82. PubMed ID: 26886404
[TBL] [Abstract][Full Text] [Related]
5. Fibromyalgia-related costs and loss of productivity: a substantial societal burden.
Lacasse A; Bourgault P; Choinière M
BMC Musculoskelet Disord; 2016 Apr; 17():168. PubMed ID: 27084363
[TBL] [Abstract][Full Text] [Related]
6. The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States.
Schaefer C; Mann R; Masters ET; Cappelleri JC; Daniel SR; Zlateva G; McElroy HJ; Chandran AB; Adams EH; Assaf AR; McNett M; Mease P; Silverman S; Staud R
Pain Pract; 2016 Jun; 16(5):565-79. PubMed ID: 25980433
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of patients with fibromyalgia in France and Germany.
Perrot S; Winkelmann A; Dukes E; Xu X; Schaefer C; Ryan K; Chandran A; Sadosky A; Zlateva G
Int J Clin Pract; 2010 Jul; 64(8):1100-8. PubMed ID: 20497264
[TBL] [Abstract][Full Text] [Related]
8. The validity and reliability of the Persian version of the Revised Fibromyalgia Impact Questionnaire.
Ghavidel Parsa B; Amir Maafi A; Haghdoost A; Arabi Y; Khojamli M; Chatrnour G; Bidari A
Rheumatol Int; 2014 Feb; 34(2):175-80. PubMed ID: 24381091
[TBL] [Abstract][Full Text] [Related]
9. Effect of fibromyalgia syndrome on the health-related quality of life and economic burden in Korea.
Kim SK; Kim SH; Lee CK; Lee HS; Lee SH; Park YB; Park HJ; Son MJ; Lee SS
Rheumatology (Oxford); 2013 Feb; 52(2):311-20. PubMed ID: 23024016
[TBL] [Abstract][Full Text] [Related]
10. Categorisation of disease severity states in fibromyalgia: a first step to support decision-making in health care policy.
Salaffi F; Di Carlo M; Arcà S; Galeazzi M
Clin Exp Rheumatol; 2018; 36(6):1074-1081. PubMed ID: 30325304
[TBL] [Abstract][Full Text] [Related]
11. Correlation of invalidation with symptom severity and health status in fibromyalgia.
Ghavidel-Parsa B; Amir Maafi A; Aarabi Y; Haghdoost A; Khojamli M; Montazeri A; Sanaei O; Bidari A
Rheumatology (Oxford); 2015 Mar; 54(3):482-6. PubMed ID: 25205826
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice.
Rivera J; Rejas-Gutiérrez J; Vallejo MA; Esteve-Vives J; De Salas-Cansado M;
Clin Exp Rheumatol; 2012; 30(6 Suppl 74):31-8. PubMed ID: 22935246
[TBL] [Abstract][Full Text] [Related]
13. Burden of illness in fibromyalgia patients with comorbid depression.
Bateman L; Sarzi-Puttini P; Burbridge CL; Landen JW; Masters ET; Bhadra Brown P; Scavone JM; Emir B; Vissing RS; Clair AG; Pauer LR
Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S106-13. PubMed ID: 27057659
[TBL] [Abstract][Full Text] [Related]
14. A Brazilian Portuguese version of the Revised Fibromyalgia Impact Questionnaire (FIQR): a validation study.
Paiva ES; Heymann RE; Rezende MC; Helfenstein M; Martinez JE; Provenza JR; Ranzolin A; de Assis MR; Pasqualin VD; Bennett RM
Clin Rheumatol; 2013 Aug; 32(8):1199-206. PubMed ID: 23604595
[TBL] [Abstract][Full Text] [Related]
15. The costs associated with sleep symptoms among patients with fibromyalgia.
Wagner JS; Chandran A; DiBonaventura M; Cappelleri JC
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):131-9. PubMed ID: 23402453
[TBL] [Abstract][Full Text] [Related]
16. Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain.
Rivera J; Rejas J; Esteve-Vives J; Vallejo MA;
Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S39-45. PubMed ID: 20074438
[TBL] [Abstract][Full Text] [Related]
17. The impact of fibromyalgia on health status according to the types, demographic background and pain index.
Ghavidel-Parsa B; Bidari A; Maafi AA; Hassankhani A; Hajiabbasi A; Montazeri A; Sanaei O; Ghalehbaghi B
Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S134-9. PubMed ID: 27157398
[TBL] [Abstract][Full Text] [Related]
18. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.
Winkelmann A; Perrot S; Schaefer C; Ryan K; Chandran A; Sadosky A; Zlateva G
Appl Health Econ Health Policy; 2011 Mar; 9(2):125-36. PubMed ID: 21332254
[TBL] [Abstract][Full Text] [Related]
19. Health services costs and their determinants in women with fibromyalgia.
Penrod JR; Bernatsky S; Adam V; Baron M; Dayan N; Dobkin PL
J Rheumatol; 2004 Jul; 31(7):1391-8. PubMed ID: 15229962
[TBL] [Abstract][Full Text] [Related]
20. The economic burden of fibromyalgia: A systematic literature review.
D'Onghia M; Ciaffi J; Ruscitti P; Cipriani P; Giacomelli R; Ablin JN; Ursini F
Semin Arthritis Rheum; 2022 Oct; 56():152060. PubMed ID: 35849890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
